Innovative drug infusion technology for laboratory animals.
Want to learn more about the capabilities of iPRECIO Programmable Pumps via highlights from Peer Reviewed publications? Our updated eBook is available now. Contact us directly via email, Contact Us Form or download from Linkedin. We are to help.
Benson et al. (2026) addressed a potential circadian confound – the time of day when infusion pumps were implanted – by using programmable iPRECIO pumps to standardize drug delivery timing across subjects, illustrating a proactive approach to experimental design Benson, Lance N., et al. "Time of Day Drives Angiotensin II–Dependent Hypertension." Hypertension 83.2 (2026): e25906. https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.25906 https://pmc.ncbi.nlm.nih.gov/articles/PMC12826273/
Slide deck from Dr. Jamie Oliver, Chief Medical Officer of Starton Therapeutics available on Labroots. Results from 3 different studies with iPRECIO pumps were shared in the webinar. Latest peer-reviewed publications from our users highlight how iPRECIO programmable pumps enable complex dosing regimens and consistent exposure profiles in free-moving subjects.
Webinar | Tuesday, October 29, 2025 Development of a Low-dose Percutaneous Delivery System for Lenalidomide in Hematologic Malignancies: From Ideation to Phase 2 Discover how Starton Therapeutics advanced their innovation journey—leveraging iPRECIO® Programmable Pumps in proof-of-concept in-vivo studies—to transform early research into clinical success. >> Register and details
Congratulations Arialys Therapeutics on your new peer-reviewed data published in Nature Communications demonstrating the potential of your lead candidate, ART5803, to address anti-NMDA receptor encephalitis and related autoimmune neuropsychiatric diseases. First time for us to see our SMP-200 pumps used for disease induction and disease treatment in a peer reviewed publication. Kanno, A., Kito, T., Maeda, M. et al. Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis. Nat Commun 16, 5292 (2025). https://doi.org/10.1038/s41467-025-60628-1
Page top
Copyright © 2025 Primetech Corporation All rights reserved.